News
Completion of Phase III trial paediatric schistosomiasis drug arpraziquantel
Today, the Pediatric Praziquantel Consortium, a public-private partnership dedicated to the development of arpraziquantel, a new pediatric medication to treat schistosomiasis in preschool-aged children, announced…
EDCTP at COVID CIRCLE online event
EDCTP is taking part in a panel discussion during the virtual event ‘What have we learned from funding COVID-19 research across the globe’ co-hosted by…
EDCTP Prizes 2020 awarded at the Tenth EDCTP Forum
EDCTP awarded its prizes for research excellence and the Pascoal Mocumbi Prize at the Tenth EDCTP Forum that was held from 17-21 October 2021 from…
The Tenth EDCTP Forum has started
The Tenth EDCTP Forum has started. This will be our first hybrid Forum, with many of the sessions taking place online and some taking place…
First EDCTP and Africa CDC-supported Epidemiologists and Biostatisticians start their training
The European & Developing Countries Clinical Trials Partnership (EDCTP) and the Africa Centres for Disease Control and Prevention (Africa CDC) are partnering to train 150…
RTS,S/AS01 malaria vaccine: EDCTP contributions and next steps
EDCTP has supported the development of the RTS,S/AS01 malaria vaccine both directly and indirectly through funding clinical research and capacity strengthening in Mozambique, Tanzania, Kenya,…
African Union and EDCTP sign Memorandum of Understanding to promote new paradigm in health
The African Union (AU) through the African Centres for Disease Control and Prevention (Africa CDC), and the European and Developing Countries Clinical Trials Partnership (EDCTP)…
Recommendations from the EDCTP/ECRIN session on clinical trial infrastructure and capacity building in Africa
The European Clinical Infrastructure Networks (ECRIN) and EDCTP hosted a session on clinical trial infrastructure and capacity building in Africa at the Africa-Europe Science and…
Biofabri and IAVI announce partnership to advance MTBVAC into efficacy trials
Biofabri and IAVI have announced their intention to partner on efficacy trials of the tuberculosis (TB) vaccine candidate MTBVAC. This highly promising vaccine candidate has…
Annual Report 2020 - focused delivery on promises
EDCTP’s Annual Report 2020 summarises the activities of the Partnership in 2020, shows the steady growth, scope and cohesion of the project portfolio, and highlights…
EDCTP principal investigators receive Queen’s Birthday Honours
On 11 June, the Queen’s Birthday Honours List 2021 was announced, this year’s list includes researchers that have played key roles in the response to…
IAVI led consortium receives EDCTP and CEPI funding for a large-scale clinical trial of Lassa fever vaccine candidate
IAVI has received an award of €22.8 million from the European & Developing Countries Clinical Trials Partnership (EDCTP) and the Coalition for Epidemic Preparedness Innovations…
New support tools for TB vaccine R&D published
The Tuberculosis Vaccine Initiative (TBVI) has coordinated the development of several new tools to support future TB vaccine clinical trials. Experts in the field together with…
Call for abstracts for the Tenth EDCTP Forum
The 10th EDCTP Forum will be held as a virtual meeting hosted from the Joaquin Chissano International Conference Centre in Maputo from 17-20 October 2021. The Forum…
World Malaria Day 2021
On World Malaria Day 2021, EDCTP joins all partners in the ‘Zero Malaria – Draw the Line Against Malaria’ campaign towards the goal of malaria…